Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial
Effekt der Ergänzung von Elektroakupunktur zur Standard-Dreifach-Antiemese bei chemotherapiebedingter Übelkeit und Erbrechen: randomisierte kontrollierte Studie
Journal of Clinical Oncology · 2024-12 · 42 (34) · 4051-4059
DOI: 10.1200/jco.24.00099 ↗Auf einen Blick
Bei Frauen mit Brustkrebs unter hoch emetogener Chemotherapie erhöhte echte Elektroakupunktur zusätzlich zur Standard-Dreifach-Antiemese die vollständige Schutzrate innerhalb von 120 Stunden.
Fragestellung
Ist die Ergänzung von Elektroakupunktur zur Standard-Dreifach-Antiemese bei CINV wirksam?
Methode
Randomisierte, verblindete, sham-kontrollierte Studie in 6 chinesischen Krankenhäusern von März 2022 bis Dezember 2023.
Ergebnisse
239 randomisierte Patient:innen; 235 beendeten die Studie. Vollständiger Schutz: 52,9 % mit echter Elektroakupunktur vs. 34,5 % mit Sham (P = .004). Weitere Endpunkte waren ebenfalls besser, außer kein Erbrechen insgesamt.
Schlussfolgerung der Autor:innen
Die Ergänzung von echter Elektroakupunktur zur Standard-Dreifach-Antiemese verbessert laut Autor:innen die Wirksamkeit der CINV-Behandlung bei Patientinnen mit Brustkrebs und HEC.
Kernaussagen
- Vollständiger Schutz: 52,9 % vs. 34,5 %
- Weitere CINV-Endpunkte verbesserten sich unter echter Elektroakupunktur
- Kein Unterschied beim Ausbleiben von Erbrechen insgesamt
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, 2024-12. Verfasst von Guoshuang Shen und 24 weiteren Autor:innen. Beteiligte Einrichtung: Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University, Xining, C…. Hauptthemen laut MEDLINE: Electroacupuncture, Nausea, Vomiting, Antiemetics. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE We aim to determine the effectiveness of adding electroacupuncture to standard triple antiemetic therapy for treating chemotherapy-induced nausea and vomiting (CINV). METHODS From March 2022 to December 2023, a randomized, blind, sham-controlled trial conducted across six Chinese hospitals investigated patients with breast cancer undergoing highly emetogenic chemotherapy (HEC). Patients were randomly assigned to either true electroacupuncture (n = 120) or sham electroacupuncture (n = 119) groups, with both groups receiving standard triple antiemetic therapy. The primary end point was the proportion of complete protection (no vomiting, no need for rescue treatment, and no significant nausea, as evaluated using the visual analog scale [VAS]) within 120 hours after receiving HEC. RESULTS Among 239 randomly assigned patients, 235 (98.3%) completed the trial. In the full analysis set, compared with the sham electroacupuncture group, the true electroacupuncture group demonstrated a significant increase in the complete protection rate from 34.5% to 52.9% ( P = .004). Additionally, true electroacupuncture also showed enhanced total control (4.3% v 13.4%; P = .014), no significant nausea (37.9% v 58.8%; P = .001), no nausea (4.3% v 13.4%; P = .014), and nausea VAS score = 0 mm (4.3% v 12.6%; P = .023). However, the occurrence of no vomiting in the overall stage was similar (76.7% v 73.9%; P = .622) in both groups. Post hoc exploratory analysis showed a significantly higher rate of complete protection during the delayed stage in the true electroacupuncture group compared with the sham electroacupuncture group, with no significant difference observed during the acute stage. CONCLUSION Adding true electroacupuncture to standard triple antiemetic therapy significantly enhances the efficacy of CINV treatment in patients with breast cancer receiving HEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University, Xining, China.
- Breast Disease Department of Qinghai Provincial Hospital of Traditional Chinese Medicine, Xining, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.
- Medical Oncology Department of General Hospital of Ningxia Medical University, Yinchuan, China.
- Department of Oncology, Lanzhou University First Hospital, Lanzhou, China.
- Department of Oncology, Lanzhou University Second Hospital, Lanzhou, China.
ORCID-Profile: Dengfeng Ren, Jiuda Zhao
Zitieren
APA
Shen, G., Ren, D., Zhao, F., Wang, M., Liu, Z., Feng, X., He, Y., Liu, X., Ling, X., Zhao, Y., Song, F., Ma, J., Li, E., She, T., Liu, Z., Li, Z., Huang, S., Chen, Y., Yang, J., …, & Zhao, J. (2024). Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial. Journal of Clinical Oncology, 42(34), 4051-4059. https://doi.org/10.1200/jco.24.00099
Vancouver
Shen G, Ren D, Zhao F, Wang M, Liu Z, Feng X, et al. Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial. Journal of Clinical Oncology. 2024;42(34):4051-4059. doi:10.1200/jco.24.00099
BibTeX
@article{Shen2024,
author = {Shen, Guoshuang and Ren, Dengfeng and Zhao, Fuxing and Wang, Miaozhou and Liu, Zhen and Feng, Xiumei and He, Yingjian and Liu, Xinlan and Ling, Xiaoling and Zhao, Yi and Song, Feixue and Ma, Jiyan and Li, Enxi and She, Tong and Liu, Zhilin and Li, Zitao and Huang, Shifen and Chen, Yongzhi and Yang, Jingru and Li, Xuan and Duan, Li and Da, Mengting and Zheng, Yonghui and Li, Yongxin and Zhao, Jiuda},
title = {Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial},
journal = {Journal of Clinical Oncology},
year = {2024},
volume = {42},
number = {34},
pages = {4051--4059},
doi = {10.1200/jco.24.00099}
}
EUVIMED